monrd0006
Medals oligonucleic drug ID monrd0006
ATC Classification -
Product Name AVT-02 UE
Synonims -
Country Germany
Company Avontec GmbH
phase -
Type decoy
Adaptation Diseases psoriasis vulgaris
Target Molecule STAT-1
Remarks A multicenter, randomized, double-blind, placebo-controlled, intraindividual-comparison phase IIa trial, to evaluate the efficacy and safety of 2% AVT-02 UE ointment in the treatment of mild to moderate psoriasis vulgaris, has been carried out.
Nucleic Acid Sequence -
Source https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000462-21/DE,
https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002765-31/DE,
https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001969-15/DE
DrugBank -
TargetProtein - UniProt P42224
TargetProtein - PDB 1BF5